Latest Commercialization News

Talga Group has locked in a binding multi-year offtake agreement with Nyobolt for its Talnode-C graphite anode, marking a key commercial milestone for its Vittangi Anode Project in Sweden.

Smartgroup Corporation Limited reported robust financial growth in 2024, driven by record customer numbers and a significant rise in electric vehicle leasing, positioning the company for a sustainable future.

EBR Systems has won FDA approval for its pioneering leadless WiSE CRT System, setting the stage for a phased US commercial rollout. The company also secured key Medicare reimbursement pathways and expanded manufacturing capacity, though financial sustainability remains a concern.

Lumos Diagnostics has secured its largest single US purchase order for its rapid respiratory test FebriDx, signaling growing adoption in American healthcare settings.

Nimy Resources has launched a Phase 2 drilling campaign at its promising Block 3 Gallium project in Western Australia, aiming to expand known mineralisation and progress towards a maiden JORC resource. The program also supports metallurgical testing critical to commercial development.

Anteris Technologies has submitted its FDA Investigational Device Exemption for the pivotal PARADIGM Trial of its DurAVR heart valve and marked a milestone of 100 patients treated, while expanding manufacturing capacity amid rising R&D costs.

Tamboran Resources has raised US$55.4 million through a private placement to fund critical drilling activities in the Beetaloo Basin, aiming for first gas production by mid-2026.

Anteris Technologies Global Corp. reported a $21.9 million net loss for Q1 2025, driven by increased R&D spending as it scales manufacturing and prepares pivotal trials for its DurAVR Transcatheter Heart Valve. The company’s recent $80 million IPO proceeds are being deployed to support these efforts and repay debt.

5E Advanced Materials has raised $6.35 million through a private placement to advance its boron and lithium project in Southern California, aiming to strengthen U.S. supply chains and move closer to commercialization.

Brazilian Critical Minerals has initiated an in-situ recovery field trial at its Ema Rare Earths Project, aiming to validate the deposit's unique characteristics and advance towards commercial production.

Commonwealth Bank of Australia reports a 45 basis point increase in its CET1 capital ratio for Q1 2025, driven by earnings despite rising risk-weighted assets. The bank maintains strong liquidity and leverage ratios above regulatory minimums.

Green Critical Minerals confirms the materiality of a formal sample request from a leading European thermal management provider, underscoring growing market interest in its VHD Graphite technology.